ATE173615T1 - Formulierung und verwendung von carotenoiden in der krebsbehandlung - Google Patents

Formulierung und verwendung von carotenoiden in der krebsbehandlung

Info

Publication number
ATE173615T1
ATE173615T1 AT93903070T AT93903070T ATE173615T1 AT E173615 T1 ATE173615 T1 AT E173615T1 AT 93903070 T AT93903070 T AT 93903070T AT 93903070 T AT93903070 T AT 93903070T AT E173615 T1 ATE173615 T1 AT E173615T1
Authority
AT
Austria
Prior art keywords
formulation
lipid
carotenoid
carotenoids
disclosed
Prior art date
Application number
AT93903070T
Other languages
English (en)
Inventor
Kapil Mehta
Roman Perez-Soler
Gabriel Lopez-Berestein
Robert P Lenk
Alan C Hayman
Original Assignee
Univ Texas
Aronex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Aronex Pharmaceuticals Inc filed Critical Univ Texas
Application granted granted Critical
Publication of ATE173615T1 publication Critical patent/ATE173615T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93903070T 1992-01-16 1993-01-13 Formulierung und verwendung von carotenoiden in der krebsbehandlung ATE173615T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82205592A 1992-01-16 1992-01-16

Publications (1)

Publication Number Publication Date
ATE173615T1 true ATE173615T1 (de) 1998-12-15

Family

ID=25235000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93903070T ATE173615T1 (de) 1992-01-16 1993-01-13 Formulierung und verwendung von carotenoiden in der krebsbehandlung

Country Status (8)

Country Link
EP (1) EP0621773B1 (de)
JP (2) JP3691054B2 (de)
AT (1) ATE173615T1 (de)
AU (1) AU3442093A (de)
CA (1) CA2128103C (de)
DE (1) DE69322252T2 (de)
ES (1) ES2128417T3 (de)
WO (1) WO1993013751A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
ES2149264T3 (es) * 1993-03-22 2000-11-01 Cognis Australia Pty Ltd Agente terapeutico para el tratamiento de melanomas.
ES2178651T3 (es) * 1993-03-22 2003-01-01 Cognis Australia Pty Ltd Compuestos carotenoides terapeuticos deispersables en agua.
AU715430B2 (en) * 1995-08-14 2000-02-03 Optigenex, Inc. Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
WO2001074384A1 (en) * 2000-03-31 2001-10-11 Aronex Pharmaceuticals, Inc. Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
WO2002032413A2 (en) * 2000-10-17 2002-04-25 Board Of Regents, The University Of Texas System A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
CN101511372B (zh) * 2006-07-07 2011-11-16 蒂尔坦制药有限公司 包含h2-阻断剂、至少一种抗炎剂和细胞毒性剂的抗癌药物组合物
CN107753473A (zh) * 2016-08-18 2018-03-06 杭州高田生物医药有限公司 一种全反式维甲酸注射剂与应用
IL315396A (en) * 2022-03-08 2024-11-01 Mastery Biotech Co Ltd Pharmaceutical composition including retinoic acid and carbohydrate and use thereof
WO2024174011A1 (pt) * 2023-02-24 2024-08-29 Rossi Bergmann Bartira Lipossoma, método de preparo de um lipossoma, composição intranasal compreendendo lipossoma, método de preparo de composição intranasal, kit e uso da composição

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
WO1989006977A1 (en) * 1988-02-04 1989-08-10 Board Of Regents, The University Of Texas System Formulation and use of retinoids in treatment of cancer and other diseases
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
DE4005711C1 (de) * 1990-02-23 1991-06-13 A. Nattermann & Cie Gmbh, 5000 Koeln, De

Also Published As

Publication number Publication date
ES2128417T3 (es) 1999-05-16
JP2005232182A (ja) 2005-09-02
EP0621773A1 (de) 1994-11-02
CA2128103C (en) 2004-12-28
DE69322252T2 (de) 1999-08-12
JP3691054B2 (ja) 2005-08-31
EP0621773B1 (de) 1998-11-25
JPH07503014A (ja) 1995-03-30
CA2128103A1 (en) 1993-07-22
AU3442093A (en) 1993-08-03
DE69322252D1 (de) 1999-01-07
WO1993013751A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
RU94045136A (ru) Композиция для ухода за кожей, способ ухода за кожей
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
HU900284D0 (en) Fungicide compositions containing acrylic acid derivatives and process for producing the active substance
EP0301781A3 (en) Cosmetic composition
DE69309340D1 (de) Stabile Natrium-Porfimerzusammensetzungen und Verfahren zu ihrer Herstellung
AU3232789A (en) Anesthetic skin moisturizing composition and method of preparing same
MY110734A (en) Improvements in or relating to dioic acids.
ATE102011T1 (de) Kosmetisches praeparat.
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
AU639323B2 (en) Cosmetic composition
AU674142B2 (en) Use of cosmetic composition
ATE173615T1 (de) Formulierung und verwendung von carotenoiden in der krebsbehandlung
GR3031691T3 (en) Composition and method for preventing and treating inflammation with immunoglobulin a
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
ATE330613T1 (de) Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
ATE115856T1 (de) Kosmetische verwendung eines mittels gegen erytheme.
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
AU5251893A (en) Lanolin/lanolin acid ester skin treatment composition
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
NO902104L (no) Kosmetisk blanding.
JPS5626842A (en) Aliphatic acid ester of beta-thujaplicin and fair-skinning cosmetic having said ester as active component
AU537117B2 (en) Alpha-cyano-4-fluoro-3-phenoxybenzyl ester
GB8824429D0 (en) U v absorption agents
JPS6483007A (en) Cosmetic
TH5131A (th) ผลิตภัณฑ์เครื่องสำอาง

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties